Novartis to run COVID-19 preliminary of antimalarial drug Kumar Jeetendra | April 20, 2020 Novartis has won the thumbs up from the U.S. Nourishment and Drug Administration to direct a randomized preliminary of jungle fever medicate hydroxychloroquine against COVID-19 illness, the Swiss drugmaker said on Monday, to check whether it helps patients. The decades-old nonexclusive medication got FDA crisis use approval this month for its unapproved use for coronavirus …
Roche says risdiplam viable in spinal muscular atrophy preliminary Kumar Jeetendra | April 28, 2020 Roche Holding AG’s risdiplam showed significant improvement in survival and motor milestones in a clinical trial for infants with type 1 spinal muscular atrophy (SMA), the Swiss drugmaker said on Tuesday. The Firefish part 2 study met its primary endpoint by demonstrating a significant increase in motor milestones in infants aged 1-7 months after 12 …
Roche gets U.S. FDA emergency use gesture for COVID-19 antibody test Kumar Jeetendra | May 3, 2020 Roche Holding AG got crisis use endorsement from the U.S. Food and Drug Administration (FDA) for a counter acting agent test to help decide whether individuals have ever been tainted with the coronavirus, the Swiss drugmaker said on Sunday. Governments, organizations and people are looking for such blood tests, to assist them with studying who …
Drugmaker Roche in converses with UK government to turn out coronavirus neutralizer test packs Kumar Jeetendra | May 14, 2020 Swiss drugmaker Roche Holding AG said on Wednesday it was in converses with the UK government to reveal its coronavirus neutralizer test units in the nation after Public Health England (PHE) discovered them solid. PHE, which led an autonomous assessment of Roche’s immunizer test a week ago, said it discovered Roche’s measure has a particularity …
Roche test gets FDA emergency use endorsement for COVID-19 patients Kumar Jeetendra | June 4, 2020 Drugmaker Roche has gotten emergency use authorisation from the U.S. Food and Drug Administration for its Elecsys IL-6 test to help distinguish serious provocative reaction in patients with affirmed COVID-19, it said on Thursday. The test can be utilized to help distinguish coronavirus patients who could be at high danger of intubation with mechanical ventilation, …
Cipla expands partnership with Roche Pharma India to further improve access to key oncology medicines Kumar Jeetendra | June 18, 2020 Mumbai 18th June 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) and Roche Products (India) Pvt. Ltd. (Roche Pharma) today announced that the two companies have entered into an agreement to provide better access to innovative medicines for patients in India. Under this agreement, Cipla will be responsible for …
Swiss drugmaker Roche says interest for Covid-19 tests surpasses production Kumar Jeetendra | June 28, 2020 Swiss drugmaker Roche can’t fulfill need for sub-atomic tests to distinguish dynamic COVID-19 diseases, its director revealed to Swiss every day Tagesanzeiger. “The interest surpasses our creation,” Christoph Franz was cited as saying in Saturday’s paper. The choice on where tests were sent to depended, in addition to other things, on contamination rates and the …
Roche’s HER2 Companion Diagnostic for Breast Cancer: FDA approval Kumar Jeetendra | July 30, 2020 Roche, Basel, Switzerland, has received FDA approval for its Ventana HER2 Dual ISH DNA Probe Cocktail assay for the detection of the human epidermal growth factor receptor 2 (HER2) biomarker in breast cancer and as a companion diagnostic for Herceptin (trastuzumab) therapy. HER2 is an important biomarker sometimes found in breast cancer, and its detection …
USFDA Approved Foundation Medicine’s FoundationOne®Liquid CDx, a Pan-Tumor Liquid Biopsy Genomic Test for Late Stage Cancer Patients now Available in India Kumar Jeetendra | November 19, 2020 Mumbai, 18 November 2020: Roche Products (India) Pvt. Ltd. (Roche Pharma India) announces the launch of FoundationOne®Liquid CDx, Foundation Medicine’s comprehensive pan-tumor liquid biopsy test for patients with solid tumors in India. US FDA approved the FoundationOne®Liquid CDx, a comprehensive genomic profiling (CGP) test on August 26. This is the first test that can analyze …
Roche partnered with Moderna to Include Antibody Test in Covid-19 Vaccine Trials Kumar Jeetendra | December 14, 2020 Roche, Basel, Switzerland, announced a partnership with Moderna Inc., Cambridge, Mass, to utilize the Elecsys Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine research trials. This will facilitate the quantitative measurement of SARS-CoV-2 Compounds and help to establish a correlation between vaccine-induced protection and degrees of anti-receptor binding domain (RBD) antibodies. Significantly, Moderna’s vaccine triggers …
Roche and GenMark Diagnostics signs Definitive Merger Agreement Kumar Jeetendra | March 20, 2021 Roche, Basel, Switzerland, and GenMark Diagnostics, Carlsbad, Calif, have entered into a definitive merger agreement for Roche to completely acquire GenMark at a price of $24.05 per share in an all-cash trade. This corresponds to a total transaction value of approximately $1.8 billion on a fully diluted basis. The merger agreement has been unanimously approved …
